Market Overview:
The global hyaluronic acid injections for joint pain market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The market is segmented on the basis of type, application, and region. On the basis of type, the knee & ankle segment is expected to dominate the market in 2018 and is projected to grow at a CAGR of 5.9% during the forecast period. This can be attributed to increasing incidence of osteoarthritis (OA) in knees across all regions.
Product Definition:
Hyaluronic acid injections are a treatment for joint pain. The injections contain a substance that helps to cushion and lubricate the joints. This can help to relieve pain and improve movement.
Knee & Ankle:
Knee and ankle are the two joints of the body which make up the knee cap and leg. They connect femur (thigh bone) to tibia (shinbone). The knee joint is made up of soft tissues, ligaments, cartilage and bones. The hyaluronic acid injections in this joint acts as a lubricant which allows free movement of joints without any pain or catching.
Hip Joint:
The hip joint is a ball-and-socket joint that allows the body to move in an anterior/posterior, left/right, and rotational manner. The hip is one of the largest joints in the human body. It consists of head; acetabulum (shaped like a bowl); neck; greater trochanter (groove on side); femoral head (ball on end of femur bone); and pelvis.
Application Insights:
The joint pain market is segmented by application into hospital pharmacies, retail pharmacies, online pharmacies and others. The hospital pharmacy segment held the largest share in 2017 due to the high usage of hyaluronic acid injections for joint pain in hospitals. This can be attributed to a large patient base suffering from acute as well as chronic conditions requiring long-term treatment.
The increasing prevalence of diseases such as rheumatoid arthritis, osteoarthritis and osteoporosis has led to an increase in demand for anti-inflammatory drugs that are used traditionally for the treatment of these disorders. As a result, there has been an upsurge in demand for hyaluronic acid injections over the past few years across all regions where these drugs are sold including North America and Europe.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of players, high awareness levels pertaining to benefits of minimally invasive procedures, and availability of technologically advanced products are some factors responsible for its dominance. Moreover, increasing cases of arthritis & osteoporosis coupled with rising geriatric population is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to growing medical tourism industry in countries such as India and China. In addition, an increase in disposable income will enable more people from developing economies go for medical treatments which would boost demand further over the next eight years.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This is expected to drive the demand for hyaluronic acid injections for joint pain, as they are effective in treating age-related joint pain.
- Growing awareness about the benefits of hyaluronic acid injections: There is growing awareness about the benefits of hyaluronic acid injections among both healthcare professionals and patients. This is likely to boost the demand for these products in the coming years.
- Technological advancements: The development of new and innovative technologies has led to the introduction of advanced hyaluronic acid products, which are more effective than traditional ones in treating joint pain. This is likely to fuel market growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hyaluronic Acid Injections for Joint Pain Market Research Report
By Type
Knee & Ankle, Hip Joint, Shoulder & Elbow, Facet Joints of the Spine, Others,
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies,
By Companies
Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet, SEIKAGAKU, Chugai Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Hyaluronic Acid Injections for Joint Pain Market Report Segments:
The global Hyaluronic Acid Injections for Joint Pain market is segmented on the basis of:
Types
Knee & Ankle, Hip Joint, Shoulder & Elbow, Facet Joints of the Spine, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Pfizer
- Sanofi
- Anika Therapeutics
- Ferring
- Bioventus
- Flexion Therapeutics
- Zimmer Biomet
- SEIKAGAKU
- Chugai Pharma
Highlights of The Hyaluronic Acid Injections for Joint Pain Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Knee & Ankle
- Hip Joint
- Shoulder & Elbow
- Facet Joints of the Spine
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hyaluronic Acid Injections for Joint Pain Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hyaluronic acid injections are a type of injection that is used to treat joint pain. Hyaluronic acid is a natural substance that is found in the body and helps to keep the joints lubricated. This can help reduce inflammation and pain in the joints.
Some of the key players operating in the hyaluronic acid injections for joint pain market are Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet, SEIKAGAKU, Chugai Pharma.
The hyaluronic acid injections for joint pain market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hyaluronic Acid Injections for Joint Pain Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hyaluronic Acid Injections for Joint Pain Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hyaluronic Acid Injections for Joint Pain Market - Supply Chain
4.5. Global Hyaluronic Acid Injections for Joint Pain Market Forecast
4.5.1. Hyaluronic Acid Injections for Joint Pain Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hyaluronic Acid Injections for Joint Pain Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hyaluronic Acid Injections for Joint Pain Market Absolute $ Opportunity
5. Global Hyaluronic Acid Injections for Joint Pain Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Type
5.3.1. Knee & Ankle
5.3.2. Hip Joint
5.3.3. Shoulder & Elbow
5.3.4. Facet Joints of the Spine
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hyaluronic Acid Injections for Joint Pain Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hyaluronic Acid Injections for Joint Pain Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hyaluronic Acid Injections for Joint Pain Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hyaluronic Acid Injections for Joint Pain Demand Share Forecast, 2019-2026
9. North America Hyaluronic Acid Injections for Joint Pain Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Type
9.7.1. Knee & Ankle
9.7.2. Hip Joint
9.7.3. Shoulder & Elbow
9.7.4. Facet Joints of the Spine
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hyaluronic Acid Injections for Joint Pain Demand Share Forecast, 2019-2026
10. Latin America Hyaluronic Acid Injections for Joint Pain Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Type
10.7.1. Knee & Ankle
10.7.2. Hip Joint
10.7.3. Shoulder & Elbow
10.7.4. Facet Joints of the Spine
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hyaluronic Acid Injections for Joint Pain Demand Share Forecast, 2019-2026
11. Europe Hyaluronic Acid Injections for Joint Pain Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hyaluronic Acid Injections for Joint Pain Market Size ad Volume Forecast by Type
11.7.1. Knee & Ankle
11.7.2. Hip Joint
11.7.3. Shoulder & Elbow
11.7.4. Facet Joints of the Spine
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hyaluronic Acid Injections for Joint Pain Demand Share, 2019-2026
12. Asia Pacific Hyaluronic Acid Injections for Joint Pain Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Type
12.7.1. Knee & Ankle
12.7.2. Hip Joint
12.7.3. Shoulder & Elbow
12.7.4. Facet Joints of the Spine
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hyaluronic Acid Injections for Joint Pain Demand Share, 2019-2026
13. Middle East & Africa Hyaluronic Acid Injections for Joint Pain Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hyaluronic Acid Injections for Joint Pain Market Size and Volume Forecast by Type
13.7.1. Knee & Ankle
13.7.2. Hip Joint
13.7.3. Shoulder & Elbow
13.7.4. Facet Joints of the Spine
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hyaluronic Acid Injections for Joint Pain Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hyaluronic Acid Injections for Joint Pain Market: Market Share Analysis
14.2. Hyaluronic Acid Injections for Joint Pain Distributors and Customers
14.3. Hyaluronic Acid Injections for Joint Pain Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Allergan
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sanofi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Anika Therapeutics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Ferring
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bioventus
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Flexion Therapeutics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Zimmer Biomet
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. SEIKAGAKU
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Chugai Pharma
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
